Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
WITHDRAWN
NCT03972111
A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox
Sponsor: SIGA Technologies
View on ClinicalTrials.gov
Summary
Phase 4, Observational Field Study in Patients Treated With TPOXX for Smallpox Disease
Official title: A Phase 4, Observational Field Study to Evaluate the Safety and Clinical Benefit of TPOXX (Tecovirimat)-Treated Patients Following Exposure to Variola Virus and Clinical Diagnosis of Smallpox Disease
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
0
Start Date
2020-01-01
Completion Date
2024-09-30
Last Updated
2026-09-10
Healthy Volunteers
No
Conditions
Interventions
DRUG
TPOXX 200Mg Capsule
TPOXX 600 mg (three 200 mg.) capsules twice daily for 14 days
Locations (1)
Investigator Site
Corvallis, Oregon, United States